Want to join the conversation?
$BDX's 1Q16 US revenue grew 1.5%, with BD Medical growth of 1.9% and BD Life Sciences growth of 0.3%. BD Medical's performance reflects strength in pharmacy solutions, infusion therapy pumps and related consumables. International revenues grew 2.2%, below the normal growth rate reflecting timing of tenders and capital installations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?